Ashwini Yenamandra

746 total citations
21 papers, 523 citations indexed

About

Ashwini Yenamandra is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Ashwini Yenamandra has authored 21 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Ashwini Yenamandra's work include Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Ashwini Yenamandra is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Ashwini Yenamandra collaborates with scholars based in United States, Canada and United Kingdom. Ashwini Yenamandra's co-authors include Courtney A. Lovejoy, David Cortez, Mahesh B. Chandrasekharan, Zhongming Zhao, Siyuan Zheng, Andrew J. Wilson, Srividya Bhaskara, Edward B. Holson, Fen Xia and Scott W. Hiebert and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Cell and American Journal of Clinical Pathology.

In The Last Decade

Ashwini Yenamandra

19 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashwini Yenamandra United States	9	363	107	100	65	61	21	523
Soumen Chakraborty India	13	434 1.2×	80 0.7×	197 2.0×	50 0.8×	82 1.3×	27	635
Alan K. Ikeda United States	11	396 1.1×	120 1.1×	156 1.6×	32 0.5×	38 0.6×	20	614
Subrata Banerjee India	13	269 0.7×	159 1.5×	92 0.9×	102 1.6×	72 1.2×	31	538
Susana Lisboa Portugal	12	241 0.7×	93 0.9×	97 1.0×	90 1.4×	46 0.8×	25	433
Yuanying Gong China	10	343 0.9×	85 0.8×	99 1.0×	70 1.1×	42 0.7×	16	520
Susana Kofman Mexico	12	270 0.7×	53 0.5×	57 0.6×	99 1.5×	76 1.2×	23	431
Daniel P. Sejas United States	10	475 1.3×	124 1.2×	146 1.5×	130 2.0×	67 1.1×	10	641
Danielle N. Yarde United States	8	232 0.6×	140 1.3×	145 1.4×	47 0.7×	65 1.1×	11	386
Roel Vandepoel Belgium	12	264 0.7×	72 0.7×	97 1.0×	61 0.9×	38 0.6×	14	439
Joseph R. Boyd United States	14	394 1.1×	101 0.9×	61 0.6×	140 2.2×	34 0.6×	29	529

Countries citing papers authored by Ashwini Yenamandra

Since Specialization

Citations

This map shows the geographic impact of Ashwini Yenamandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwini Yenamandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwini Yenamandra more than expected).

Fields of papers citing papers by Ashwini Yenamandra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwini Yenamandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwini Yenamandra. The network helps show where Ashwini Yenamandra may publish in the future.

Co-authorship network of co-authors of Ashwini Yenamandra

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwini Yenamandra. A scholar is included among the top collaborators of Ashwini Yenamandra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwini Yenamandra. Ashwini Yenamandra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yenamandra, Ashwini, Rebecca B. Smith, Sung‐Hae Kang, et al.. (2022). Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working group. Cancer Genetics. 268-269. 1–21. 4 indexed citations

Smith, Rebecca B., et al.. (2021). Clinical diagnosis of neurofibromatosis type I in multiple family members due to cosegregation of a unique balanced translocation with disruption of the NF1 locus: Testing considerations for accurate diagnosis. American Journal of Medical Genetics Part A. 185(4). 1222–1227. 2 indexed citations

Yenamandra, Ashwini, et al.. (2021). Artificial Intelligence in Plasma Cell Myeloma: Neural Networks and Support Vector Machines in the Classification of Plasma Cell Myeloma Data at Diagnosis. Journal of Pathology Informatics. 12(1). 35–35. 6 indexed citations

Sethi, Tarsheen, Ashwini Yenamandra, David Morgan, et al.. (2021). Primary sinonasal large B cell lymphoma is as histopathologically heterogeneous as systemic large B cell lymphoma but may show subtype-specific tropism for specific sinonasal anatomic sites. Journal of Hematopathology. 14(4). 269–275.

Akkari, Yassmine, Hélène Bruyèrè, R. Tanner Hagelstrom, et al.. (2020). Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia. Cancer Genetics. 243. 52–72. 14 indexed citations

Yenamandra, Ashwini, Saara Kaviany, Scott C. Borinstein, Debra L. Friedman, & Alexandra E. Kovach. (2019). BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use. Laboratory Medicine. 50(4). 401–405. 3 indexed citations

Sethi, Tarsheen, Alexandra E. Kovach, Natalie S. Grover, et al.. (2019). Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma. Leukemia & lymphoma. 60(12). 2880–2889. 15 indexed citations

Xu, Xinjie, Christine R. Bryke, Madina Sukhanova, et al.. (2018). Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group. Cancer Genetics. 228-229. 218–235. 15 indexed citations

Kanagal‐Shamanna, Rashmi, Jennelle C. Hodge, Tracy Tucker, et al.. (2018). Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms. Cancer Genetics. 228-229. 197–217. 25 indexed citations

10.

Wheeler, Ferrin C., Annette S. Kim, Claudio A. Mosse, et al.. (2018). Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-up. American Journal of Clinical Pathology. 149(5). 418–424. 9 indexed citations

11.

Akkari, Yassmine, Hélène Bruyèrè, Beth A. Pitel, et al.. (2018). 19. Evidence-based review of genomic aberrations in T-ALL: Strategy and progress of CGC T-ALL Working Group. Cancer Genetics. 226-227. 43–43. 1 indexed citations

12.

Yenamandra, Ashwini. (2017). Unique RUNX1 Gene Rearrangements in Acute Myeloid Leukemia Identified (AML). 1 indexed citations

13.

Hodge, Jennelle C., Rashmi Kanagal‐Shamanna, Xinjie Xu, et al.. (2017). Genomic Copy Number Aberrations and Copy Neutral Loss of Heterozygosity Evaluation in Myeloid Neoplasms: Evidence-Based Recommendations for Clinical Genetic Testing From the Myeloid Malignancies Working Group of the Cancer Genomics Consortium. Cancer Genetics. 214-215. 37–37. 1 indexed citations

14.

Yenamandra, Ashwini. (2016). A Data Science Approach to Identify Previously Unknown Indicators that Could Lead to the Prevention of Suicide in USA. 2(4). 1 indexed citations

15.

Wang, Xuan J., Gabriel K. Griffin, Ashwini Yenamandra, et al.. (2016). Transformation of follicular lymphoma into classical Hodgkin lymphoma showing t(14;18). 1(1). 2 indexed citations

16.

Yenamandra, Ashwini, et al.. (2015). Variant Translocation of ETV6 and RUNX1 in a Case of Pediatric Acute Lymphoblastic Leukemia. Figshare. 1–2.

17.

Cohen, Daniel N., Bruce Greig, Ashwini Yenamandra, et al.. (2014). The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.. PubMed. 7(9). 5738–49. 40 indexed citations

18.

Yenamandra, Ashwini, et al.. (2014). Detection of Genomic Imbalances Involved in Common Chromosomal Rearrangements of Acute Leukemia by Cytogenomic SNP Microarray Analysis. Cancer Genetics. 207(6). 289–290. 3 indexed citations

19.

Chmielecki, Juliann, Martin Peifer, Agnès Viale, et al.. (2011). Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204‐PDGFRB fusion in a patient with recurrent T‐ALL and an associated myeloproliferative neoplasm. Genes Chromosomes and Cancer. 51(1). 54–65. 15 indexed citations

20.

Bhaskara, Srividya, Sarah K. Knutson, Guochun Jiang, et al.. (2010). Hdac3 Is Essential for the Maintenance of Chromatin Structure and Genome Stability. Cancer Cell. 18(5). 436–447. 287 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact